Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M79,533Revenue $M19,616Net Margin (%)11.2Z-Score3.7
Enterprise Value $M82,777EPS $2.2Operating Margin %15.4F-Score4
P/E(ttm))32.1Cash Flow Per Share $5.4Pre-tax Margin (%)13.9Higher ROA y-yN
Price/Book5.210-y EBITDA Growth Rate %10.8Quick Ratio0.8Cash flow > EarningsY
Price/Sales3.95-y EBITDA Growth Rate %-6.0Current Ratio1.1Lower Leverage y-yN
Price/Cash Flow9.1y-y EBITDA Growth Rate %-39.0ROA % (ttm)7.4Higher Current Ratio y-yN
Dividend Yield %2.8Insider Buy (3m)0ROE % (ttm)15.1Less Shares Outstanding y-yY
Payout Ratio %88.0Shares Outstanding M1,111ROI % (ttm)23.7Gross Margin Increase y-yN

Gurus Latest Trades with LLY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LLYCharles Brandes 2014-12-31 Reduce-1.85%$61.9 - $72.83
($67.53)
$ 71.586%Reduce -92.65%169,348
LLYRichard Pzena 2014-12-31 Sold Out -0.15%$61.9 - $72.83
($67.53)
$ 71.586%Sold Out0
LLYKen Fisher 2014-12-31 Add0.07%$61.9 - $72.83
($67.53)
$ 71.586%Add 383.26%578,992
LLYCharles Brandes 2014-09-30 Reduce-0.29%$60.35 - $66.59
($63.3)
$ 71.5812%Reduce -14.27%2,303,062
LLYHOTCHKIS & WILEY 2014-09-30 Reduce-0.12%$60.35 - $66.59
($63.3)
$ 71.5812%Reduce -10.92%4,321,666
LLYKen Fisher 2014-09-30 Add0.02%$60.35 - $66.59
($63.3)
$ 71.5812%Add 2742.47%119,810
LLYDavid Dreman 2014-09-30 Reduce-0.02%$60.35 - $66.59
($63.3)
$ 71.5812%Reduce -84.40%900
LLYGeorge Soros 2014-09-30 Sold Out -0.02%$60.35 - $66.59
($63.3)
$ 71.5812%Sold Out0
LLYDodge & Cox 2014-09-30 Add$60.35 - $66.59
($63.3)
$ 71.5812%Add 20.38%42,464
LLYJoel Greenblatt 2014-09-30 Reduce$60.35 - $66.59
($63.3)
$ 71.5812%Reduce -27.37%5,628
LLYHOTCHKIS & WILEY 2014-06-30 Add0.73%$58.21 - $63.1
($59.62)
$ 71.5817%Add 199.70%4,851,480
LLYVanguard Health Care Fund 2014-06-30 Reduce-0.15%$58.21 - $63.1
($59.62)
$ 71.5817%Reduce -3.98%21,982,700
LLYGeorge Soros 2014-06-30 Buy 0.02%$58.21 - $63.1
($59.62)
$ 71.5817%New holding50,441
LLYHOTCHKIS & WILEY 2014-03-31 Buy 0.35%$50.73 - $59.85
($55.61)
$ 71.5822%New holding1,618,802
LLYJoel Greenblatt 2014-03-31 Reduce-0.16%$50.73 - $59.85
($55.61)
$ 71.5822%Reduce -93.61%9,016
LLYVanguard Health Care Fund 2013-12-31 Add0.67%$47.65 - $51.34
($50.05)
$ 71.5830%Add 22.98%22,895,000
LLYCharles Brandes 2013-12-31 Add0.19%$47.65 - $51.34
($50.05)
$ 71.5830%Add 12.57%2,711,949
LLYJoel Greenblatt 2013-12-31 Add0.11%$47.65 - $51.34
($50.05)
$ 71.5830%Add 201.79%141,121
LLYKen Fisher 2013-12-31 Buy $47.65 - $51.34
($50.05)
$ 71.5830%New holding4,429
LLYVanguard Health Care Fund 2013-09-30 Add0.46%$49.92 - $54.96
($52.42)
$ 71.5827%Add 16.91%18,617,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LLY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LILLY ENDOWMENT INC10% Owner 2015-03-30Sell180,000$73.94-2.08view
LILLY ENDOWMENT INC10% Owner 2015-03-23Sell190,000$76.97-5.94view
Fry Stephen FSVP, HR & Diversity 2015-03-09Sell4,000$69.274.52view
Zakrowski Donald AChief Accounting Officer 2015-02-05Sell374$71.031.93view
Rice Derica WEVP-Global Services and CFO 2015-02-04Sell5,316$703.43view
Lundberg Jan MEVP,Science&Tech and Pres. LRL 2015-02-04Sell11,085$70.083.31view
Ricks David ASVP and Pres, Lilly Bio-Meds 2015-02-04Sell3,147$69.993.44view
Lundberg Jan MEVP,Science&Tech and Pres. LRL 2015-02-03Sell121,711$70.782.29view
Rice Derica WEVP-Global Services and CFO 2015-02-02Sell10,068$71.840.78view
Ricks David ASVP and Pres, Lilly Bio-Meds 2015-02-02Sell4,769$71.511.24view

Press Releases about LLY :

    Quarterly/Annual Reports about LLY:

    News about LLY:

    Articles On GuruFocus.com
    What Are The Intrinsic Factors Contributing To Pfizer’s Stock Movement? Mar 27 2015 
    Eli Lilly Inks Major Deal In China To Develop Oncology Segment Mar 23 2015 
    Box Inc. Declares Mixed Bag Q4 Results for 2015 Mar 13 2015 
    Primecap Management's Annual Shareholder Letter 2014 Mar 09 2015 
    FDA Approves Sanofi’s New Diabetes Drug Feb 27 2015 
    Feeling Good With This Med Company Jan 20 2015 
    Sarah Ketterer Dives in when Others Pull Out Nov 14 2014 
    Weekly 52-Week Highs Highlight: LLY, BG, NVS, HRL Sep 07 2014 
    Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures Aug 28 2014 
    Eli Lilly is on the Right Track Jun 25 2014 


    More From Other Websites
    Eli Lilly (LLY) Stock Rises Today Following Earnings Beat Apr 23 2015
    Lilly profit beats estimates, helped by cost cuts Apr 23 2015
    Eli Lilly Beats on 1Q Earnings by Wide Margin, Affirms View - Analyst Blog Apr 23 2015
    Drug Companies Pin Hopes On TrialReach To Enroll Patients In Clinical Trials Faster Apr 23 2015
    Eli Lilly Results Top Expectations Apr 23 2015
    Early movers: PBR, MMM, CAT & more Apr 23 2015
    Eli Lilly (LLY) Beats on 1Q Earnings & Revenues - Tale of the Tape Apr 23 2015
    LLY CFO: Here's what's driving profits Apr 23 2015
    Q1 2015 Eli Lilly and Co Earnings Release - Before Market Open Apr 23 2015
    Lilly Reports First-Quarter 2015 Results Apr 23 2015
    Eli Lilly Earnings Beat Estimates on New Drugs and Higher Prices Apr 23 2015
    Lilly tops Street 1Q forecasts Apr 23 2015
    Lilly tops Street 1Q forecasts Apr 23 2015
    LILLY ELI & CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 23 2015
    Lilly profit falls 27 percent, hurt by strong dollar Apr 23 2015
    6:29 am Eli Lilly beats by $0.13, reports revs in-line; reaffirms FY15 guidance Apr 23 2015
    Lilly Reports First-Quarter 2015 Results Apr 23 2015
    Earnings deluge could support new highs Apr 23 2015
    Divestment gains boost net earnings at drug company Novartis Apr 23 2015
    Divestment gains boost net earnings at drug company Novartis Apr 23 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK